NO910735L - Krystallinsk salt av 4-(di-n-propyl)amino-6-aminokarbonyl-1,2,3,4,5-tetrahydrobenz(cd)indolhippurat - Google Patents

Krystallinsk salt av 4-(di-n-propyl)amino-6-aminokarbonyl-1,2,3,4,5-tetrahydrobenz(cd)indolhippurat

Info

Publication number
NO910735L
NO910735L NO91910735A NO910735A NO910735L NO 910735 L NO910735 L NO 910735L NO 91910735 A NO91910735 A NO 91910735A NO 910735 A NO910735 A NO 910735A NO 910735 L NO910735 L NO 910735L
Authority
NO
Norway
Prior art keywords
aminocarbonyl
propyl
amino
tetrahydrobenze
indolhippurate
Prior art date
Application number
NO91910735A
Other languages
English (en)
Other versions
NO174149B (no
NO910735D0 (no
NO174149C (no
Inventor
Thomas Joseph Kress
David Lee Varie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO910735D0 publication Critical patent/NO910735D0/no
Publication of NO910735L publication Critical patent/NO910735L/no
Publication of NO174149B publication Critical patent/NO174149B/no
Publication of NO174149C publication Critical patent/NO174149C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO910735A 1990-02-26 1991-02-25 Fremgangsmåte for fremstilling av 4-(di-n-propyl)-amino-6-aminokarbonyl-1,3,4,5-tetrahydrobenz-(cd)indolhippurat NO174149C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (4)

Publication Number Publication Date
NO910735D0 NO910735D0 (no) 1991-02-25
NO910735L true NO910735L (no) 1991-08-27
NO174149B NO174149B (no) 1993-12-13
NO174149C NO174149C (no) 1994-03-23

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910735A NO174149C (no) 1990-02-26 1991-02-25 Fremgangsmåte for fremstilling av 4-(di-n-propyl)-amino-6-aminokarbonyl-1,3,4,5-tetrahydrobenz-(cd)indolhippurat

Country Status (28)

Country Link
US (1) US5397799A (no)
EP (1) EP0444852B1 (no)
JP (1) JP3157007B2 (no)
KR (1) KR100208114B1 (no)
CN (1) CN1027503C (no)
AT (1) ATE126506T1 (no)
AU (1) AU629453B2 (no)
BR (1) BR9100767A (no)
CA (1) CA2037099C (no)
CY (1) CY1887A (no)
DE (1) DE69112099T2 (no)
DK (1) DK0444852T3 (no)
ES (1) ES2077796T3 (no)
FI (1) FI95464C (no)
GR (1) GR3017940T3 (no)
HK (1) HK175495A (no)
HU (1) HU217118B (no)
IE (1) IE67801B1 (no)
IL (1) IL97306A (no)
LV (1) LV10251B (no)
NO (1) NO174149C (no)
NZ (1) NZ237181A (no)
PT (1) PT96852B (no)
RU (2) RU2034837C1 (no)
SG (1) SG69975A1 (no)
TW (1) TW219933B (no)
YU (1) YU47594B (no)
ZA (1) ZA911258B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz] [DC indoles and a process for making their pure enantiomers
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
TW248556B (no) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
EP2327696A1 (en) 2006-06-26 2011-06-01 Warner Chilcott Company, LLC Prolyl hydroxylase inhibitors and methods of use
NZ600400A (en) 2009-11-06 2014-09-26 Aerpio Therapeutics Inc Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
NO2686520T3 (no) 2011-06-06 2018-03-17
MX2013014310A (es) 2011-06-06 2014-01-23 Akebia Therapeutics Inc Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer.
NZ753905A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
TWI788702B (zh) 2013-11-15 2023-01-01 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
YU47594B (sh) 1995-10-24
RU2083561C1 (ru) 1997-07-10
NO174149B (no) 1993-12-13
HK175495A (en) 1995-11-24
IE910625A1 (en) 1991-08-28
AU7197191A (en) 1991-08-29
GR3017940T3 (en) 1996-02-29
KR910021375A (ko) 1991-12-20
JPH04217662A (ja) 1992-08-07
CA2037099C (en) 2001-09-11
CY1887A (en) 1996-04-05
YU32791A (sh) 1994-01-20
KR100208114B1 (ko) 1999-07-15
EP0444852A2 (en) 1991-09-04
HUT56542A (en) 1991-09-30
SG69975A1 (en) 2000-01-25
EP0444852A3 (en) 1992-02-19
JP3157007B2 (ja) 2001-04-16
EP0444852B1 (en) 1995-08-16
ES2077796T3 (es) 1995-12-01
LV10251A (lv) 1994-10-20
DE69112099T2 (de) 1996-02-08
ATE126506T1 (de) 1995-09-15
IL97306A0 (en) 1992-05-25
TW219933B (no) 1994-02-01
FI910895A (fi) 1991-08-27
US5397799A (en) 1995-03-14
PT96852A (pt) 1991-10-31
FI95464B (fi) 1995-10-31
NZ237181A (en) 1992-06-25
FI95464C (fi) 1996-02-12
IL97306A (en) 1996-10-16
PT96852B (pt) 1998-07-31
CA2037099A1 (en) 1991-08-27
CN1054589A (zh) 1991-09-18
DE69112099D1 (de) 1995-09-21
CN1027503C (zh) 1995-01-25
HU217118B (hu) 1999-11-29
DK0444852T3 (da) 1995-12-11
FI910895A0 (fi) 1991-02-25
LV10251B (en) 1995-04-20
ZA911258B (en) 1992-10-28
NO910735D0 (no) 1991-02-25
IE67801B1 (en) 1996-05-01
NO174149C (no) 1994-03-23
AU629453B2 (en) 1992-10-01
RU2034837C1 (ru) 1995-05-10
BR9100767A (pt) 1991-10-29

Similar Documents

Publication Publication Date Title
NO910735L (no) Krystallinsk salt av 4-(di-n-propyl)amino-6-aminokarbonyl-1,2,3,4,5-tetrahydrobenz(cd)indolhippurat
AU6666990A (en) Indole derivatives
IE782325L (en) TETRAHYDROBENZ £cd| INDOLES
DK0396083T3 (da) Heterocykliske N-oxidderivater af substituerede benzo(5,6)-cycloheptapyridiner, præparater og anvendelsesfremgangsmåder
NO894539L (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
ES2133303T3 (es) 1,3,4,5-tetrahidrobenzo(cd)indoles 6-heterociclicos-4-amino.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
RU92004575A (ru) Кристаллическая соль 4-(ди-н-пропил) амино-6-аминокарбонил-1,3,4,5-тетрагидробенз (cd) индола и ее 4p и 4s-изомеры
NO890969D0 (no) Fremgangsmaate for fremstilling av isoindolinderivater.
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
AU8240791A (en) 6-substituted-hexahydrobenz(cd)indoles
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
AU6791790A (en) 5-(2-methyl-4,4,4-trifluorobutyl-carbamoyl)indole derivatives
AU7476787A (en) Indole derivatives
AU600934C (en) Indole derivatives and their 5-ht antagonist effects
PL286424A1 (en) Method of obtaining novel indole derivatives
AU7004987A (en) Indole derivatives and their 5-ht antagonist effects
PL274219A1 (en) Method of obtaining novel derivatives of 4-oxo-1,2,3,4-tetrahydrocinnoline
PL297066A1 (en) Method of obtaining indole derivatives